Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry.
暂无分享,去创建一个
M. Jeong | I. Seong | K. Seung | Seung‐Jung Park | Y. Jang | Hyo‐Soo Kim | Y. Song | Jin‐Ho Choi | Seung‐Hyuk Choi | H. Gwon | Sang Hoon Lee | J. Hahn | S. Rha | J. Yoon | S. Tahk | Ju-Young Yang
[1] A. Colombo,et al. Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations. , 2008, American heart journal.
[2] E. Mahmud,et al. Clinical ResearchInterventional CardiologyClinical Efficacy of Drug-Eluting Stents in Diabetic Patients: A Meta-Analysis , 2008 .
[3] Peter L Duffy,et al. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group. , 2007, Journal of the American College of Cardiology.
[4] A. Colombo,et al. Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Unsettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease) , 2007, Circulation.
[5] P. Serruys,et al. Drug-Eluting Stent Update 2007: Part I: A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same? , 2007, Circulation.
[6] A. Colombo,et al. Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice. , 2007, Journal of the American College of Cardiology.
[7] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[8] P. Serruys,et al. The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus. , 2006, European heart journal.
[9] I. Seong,et al. Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease , 2006, Circulation.
[10] P. Serruys,et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. , 2006, JAMA.
[11] A. Kastrati,et al. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. , 2006, European heart journal.
[12] J. Suárez de Lezo,et al. [A new classification of coronary bifurcation lesions]. , 2006, Revista espanola de cardiologia.
[13] Alfonso Medina,et al. Una clasificación simple de las lesiones coronarias en bifurcación , 2006 .
[14] A. Kastrati,et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. , 2005, The New England journal of medicine.
[15] F. Eberli,et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. , 2005, The New England journal of medicine.
[16] P. Serruys,et al. Treatment of de novo bifurcation lesions: comparison of Sirolimus- and Paclitaxel-eluting stents. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[17] A. Kastrati,et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. , 2005, JAMA.
[18] P. Serruys,et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. , 2004, The American journal of cardiology.
[19] Antonio Colombo,et al. Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions , 2004, Circulation.
[20] G. Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.
[21] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[22] N Breslow,et al. Covariance adjustment of relative-risk estimates in matched studies. , 1982, Biometrics.
[23] J. Suárez de Lezo,et al. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. , 2007, American heart journal.